LYCOS RETRIEVER 
Wyeth: Cushing
built 815 days ago
Wyeth collects personal information for a variety of purposes. Generally, the purpose for collecting your personal information will be explained to you, in clear language, at the time of collection. Where the purpose for collecting personal information is obvious, your consent is implied.
Source:
Closed Loop Marketing is a critical initiative for Wyeth, enabling them to leverage their customer segmentation model to provide customers with sound, clinical information in a highly compliant manner. Wyeth announced the results of the program recently at the Annual Eye for Pharma Sales Force Effectiveness Conference.
Source:
In 2003 Wyeth reportedly contributed funds to a not-for-profit support group, The Meningitis Centre, which lobbies the Australian Government to introduce universal immunisation against pneumococcal disease.[3]. Wyeth produces the only pneumococcal vaccine approved for young children in Australia.
Source:
Many Wyeth employees typically receive 50-100 e-mails a day and were finding it increasingly difficult and time-consuming to manage large amounts of e-mail, along with unwanted junk mail. Employees needed a better interface to help organize, personalize and prioritize their e-mail to improve response time and overall efficiency.
Source:
Wyeth is accountable to all of its victims, not just the ones it chooses to repay. If Wyeth will not pay victims of Fen-Phen in a timely manner, then the victims' rights to hold Wyeth accountable in court should be restored.
Source:
HORSHAM, Pa., Apr 12, 2004 /PRNewswire-FirstCall via COMTEX/ -- Centocor, Inc. today announced it has completed its acquisition of the former Wyeth (NYSE: WYE) St. Louis, MO, biopharmaceutical manufacturing facility. The transaction was announced on March 26, 2004.
Source:
MORE ABOUT
Cushing